Celcuity Inc.
CELCNasdaqCIK 1603454HealthcareFiscal year ends Dec 31
Reports and events: 154 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0212:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-411297 |
| 2026-09-3012:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408353 |
| 2026-08-2612:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-365975 |
| 2026-08-1321:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349608 |
| 2026-08-1320:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349227 |
| 2026-07-1621:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-084327 |
| 2026-07-1520:05 ET | 8-K/A | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-033357 |
| 2026-07-1521:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-033223 |
| 2026-06-0820:10 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-027717 |
| 2026-06-0212:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026761 |
| 2026-05-2011:30 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001493152-26-024510 |
| 2026-05-1820:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-024175 |
| 2026-05-1421:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023180 |
| 2026-05-1420:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023065 |
| 2026-05-0121:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020918 |
| 2026-04-0220:30 ET | DEF 14A | Proxy statementPeriod 2026-04-02 | 0001493152-26-014937 |
| 2026-03-2611:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-012801 |
| 2026-03-2520:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012668 |
| 2026-03-2420:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-033844 |
| 2026-03-0923:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-26-000251 |
| 2026-02-1221:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006444 |
| 2026-01-1622:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-26-000056 |
| 2025-11-1721:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-023897 |
| 2025-11-1322:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022401 |
| 2025-11-1221:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021903 |
| 2025-10-2010:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-018565 |
| 2025-09-1011:58 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-027025 |
| 2025-08-1822:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-25-000648 |
| 2025-08-1421:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024148 |
| 2025-08-1420:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-024007 |
| 2025-08-0121:41 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-073189 |
| 2025-08-0120:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021894 |
| 2025-07-3120:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021739 |
| 2025-07-2912:52 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021274 |
| 2025-07-2811:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021095 |
| 2025-06-3011:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-017043 |
| 2025-05-1621:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-011273 |
| 2025-05-1521:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-011053 |
| 2025-05-1420:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010308 |
| 2025-04-0121:00 ET | DEF 14A | Proxy statementPeriod 2025-04-01 | 0001641172-25-002114 |
| 2025-03-3121:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001826 |
| 2025-03-3120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001698 |
| 2024-12-0621:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-049089 |
| 2024-11-1422:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-046022 |
| 2024-11-1421:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045804 |
| 2024-10-0920:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-040594 |
| 2024-08-2820:05 ET | DEF 14A | Proxy statementPeriod 2024-08-28 | 0001493152-24-034185 |
| 2024-08-1421:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-032372 |
| 2024-08-1420:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-032197 |
| 2024-05-3121:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-022227 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.